v3.25.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Balance at the beginning at Jun. 30, 2024 $ 47,248 $ 1 $ 238,398 $ (190,259) $ (892)
Balance at the beginning (In shares) at Jun. 30, 2024   10,086,119      
Exercise of pre-funded warrants, Shares   1,768,454      
Exercise of Series 2 warrants 1,655   1,655    
Exercise of Series 2 warrants (In shares)   857,845      
Exercise of common warrants 20,002   20,002    
Exercise of common warrants (Shares)   5,181,347      
Share-based compensation 435   435    
Foreign currency translation gain (101)       (101)
Net loss (5,059)     (5,059)  
Balance at end at Sep. 30, 2024 64,180 $ 1 260,490 (195,318) (993)
Balance at end (In shares) at Sep. 30, 2024   17,893,765      
Balance at the beginning at Jun. 30, 2024 47,248 $ 1 238,398 (190,259) (892)
Balance at the beginning (In shares) at Jun. 30, 2024   10,086,119      
Foreign currency translation gain 204        
Net loss (14,611)        
Balance at end at Dec. 31, 2024 75,941 $ 1 281,498 (204,870) (688)
Balance at end (In shares) at Dec. 31, 2024   23,451,475      
Balance at the beginning at Sep. 30, 2024 64,180 $ 1 260,490 (195,318) (993)
Balance at the beginning (In shares) at Sep. 30, 2024   17,893,765      
Exercise of pre-funded warrants, Shares   606,129      
Exercise of Series 2 warrants 1,240   1,240    
Exercise of Series 2 warrants (In shares)   642,160      
Exercise of common warrants 16,630   16,630    
Exercise of common warrants (Shares)   4,309,421      
Share-based compensation 3,138   3,138    
Foreign currency translation gain 305       305
Net loss (9,552)     (9,552)  
Balance at end at Dec. 31, 2024 75,941 $ 1 281,498 (204,870) (688)
Balance at end (In shares) at Dec. 31, 2024   23,451,475      
Balance at the beginning at Jun. 30, 2025 97,295 $ 2 326,308 (228,176) (839)
Balance at the beginning (In shares) at Jun. 30, 2025   26,250,469      
Share-based compensation 5,180   5,180    
Foreign currency translation gain 89       89
Net loss (8,965)     (8,965)  
Balance at end at Sep. 30, 2025 93,599 $ 2 331,488 (237,141) (750)
Balance at end (In shares) at Sep. 30, 2025   26,250,469      
Balance at the beginning at Jun. 30, 2025 97,295 $ 2 326,308 (228,176) (839)
Balance at the beginning (In shares) at Jun. 30, 2025   26,250,469      
Foreign currency translation gain (44)        
Net loss (20,802)        
Balance at end at Dec. 31, 2025 187,361 $ 3 437,219 (248,978) (883)
Balance at end (In shares) at Dec. 31, 2025   34,254,907      
Balance at the beginning at Sep. 30, 2025 93,599 $ 2 331,488 (237,141) (750)
Balance at the beginning (In shares) at Sep. 30, 2025   26,250,469      
Issuance of common stock sold for cash, net of offering costs of $6,265 (Shares)   7,740,370      
Issuance of common stock sold for cash, net of offering costs of $6,265 98,230 $ 1 98,229    
Exercise of pre-funded warrants, Shares   200,276      
Exercise of Series 2 warrants 123   123    
Exercise of Series 2 warrants (In shares)   63,792      
Share-based compensation 7,379   7,379    
Foreign currency translation gain (133)       (133)
Net loss (11,837)     (11,837)  
Balance at end at Dec. 31, 2025 $ 187,361 $ 3 $ 437,219 $ (248,978) $ (883)
Balance at end (In shares) at Dec. 31, 2025   34,254,907